Starna Therapeutics

Developer of RNA-based drugs for multiple diseases

placeSuzhou, Jiangsu, China calendar_todayFounded 2021 language starnatx.com

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 31 times.

YearFilings
20243
20251

Social engagement

Social engagement: 417 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include LYFE Capital.

Investor typeCountShare
Venture capital563%
Private equity338%
Coming soon